Navigation Links
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software
Date:10/14/2009

e version of OpenClinica to-date."

As open source software, OpenClinica is free for organizations to use and modify. The software may be downloaded from http://www.openclinica.org with installation scripts as well as upgrade scripts for users utilizing the previous version of OpenClinica. A public demonstration instance is available at http://demo2.openclinica.org/OpenClinica-3.0.

OpenClinica Enterprise, the commercial distribution of OpenClinica, is available through Akaza Research. More information see http://www.openclinica.org/Enterprise.

Webinar Presentation of OpenClinica 3.0

Akaza Research will be conducting a webinar presentation of OpenClinica 3.0 on October 28, 2009 to demonstrate the new product and answer questions form the community. Registration for this event is free.

Wednesday, October 28 @ 9:30 -11:00 Eastern Time U.S. (GMT -4:00) - Register Here
Wednesday, October 28 @ 18:00 - 19:30 Eastern Time U.S. (GMT -4:00) - Register Here

About OpenClinica®

OpenClinica is open source, web-based clinical trials software for electronic data capture (EDC) and clinical trial data management. OpenClinica facilitates data collection via electronic case report forms (eCRFs), and provides tools for data management and productive monitoring of clinical trials. OpenClinica supports CDISC standards and is designed to be complia
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

1

GOOD

Page: 1 2 3

Related biology technology :

1. New Survey Shows Devastating Impact of Rheumatoid Arthritis Pain on Intimate Relations
2. Aldrichimica Acta Ranked First in Organic Chemistry by Impact Factor
3. Plastics that convert light to electricity could have a big impact
4. Novel method predicts impact of a covert anthrax release
5. Novel method predicts impact of a covert anthrax release
6. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
7. World Micromachine Summit highlights technologies impacting energy and the environment
8. Event Alert: SPL R4 Compliance and its Impact on Regulatory Submission Processes
9. What Will Be the Impact of Programs of Study?
10. PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
11. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software 
Impact of Open Source Software on Clinical Trials Grows With Release of OpenClinica 3.0 Electronic Data Capture Software
(Date:11/24/2009)... , SAN MATEO, Calif., Nov. 24 /PRNewswire... biopharmaceutical company focused on developing a..., announced today that Anthony DiTonno, President ...nt at the 21st Annual Piper Jaffray Health Care Co... York Palace Hotel in New York, New York. ,, M...
(Date:11/24/2009)... The FBI recently approved th...tories participating in or generating DNA records ... Madison, WI USA (PRWEB) -- The FBI rec...ystem for use by laboratories participating in, o...ex System (NDIS). NDIS currently contains more tha...
(Date:11/24/2009)... , DUBLIN, November 24 /PRNewswire-First...e global specialty biopharmaceutical company, toda...opean Medicines Agency for,velaglucerase alfa, the...nt,for the treatment of Type 1 Gaucher disease. Th...erase alfa that has been submitted, with previous,...
(Date:11/24/2009)... , BOZEN, Italy, November 24 /PRNewswi... formed a new Canadian joint venture with a group ...o-based company will operate under the,name Health...nd support,Health Robotics, i.v. Room of the Futur...t offerings i.v.STATION(TM), i.v.SOFT(TM), and OMM...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 3
...e nation,s top-10 GPOs(1), IRVINE, Calif., Jan. 2...ead-Through Motion and Low Perfusion pulse,oximetr...lier agreement,with HealthTrust Purchasing Group (...ies, including acute care hospitals, ambulatory su...practices, with an annual,purchasing volume of mor...
...surement of Women,s Ovarian ...ductive Specialists (GRS),today announced it will ...the Repromedix Plan Ahead(TM) test, an innovative ...s egg supply by combining multiple factors,includi...Inhibin B, and,FSH. The window of opportunity for ...
...t renin inhibitor with the diuretic hydroc...ow combination of Tekturna and HCTZ resulted in si...ompared to either drug alone - Many treated patie... medicines - single-tablet combinations simplify ...f pills patients take, EAST HANOVER, N.J., Jan. 2...
Other Biology Technology:Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 2Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 3Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group 4Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 2Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Women's Biological Clock 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 2Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 3Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 4Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure 5
(Date:11/25/2009)...eptember 11, firefighters, police officers and amb... the World Trade Center complex. They battled to s...ed for survivors, tackled fires and evacuated as m...d an estimated 17,000 people. And making their job...ns: frightened workers and their relatives jammed ...
(Date:11/25/2009)... JOLLA, CAWhen you eat may be just as vital to you... Salk Institute for Biological Studies. Their expe... waning of thousands of genes in the liverthe body...food intake and not by the body,s circadian clock ...me determines the activity of a large number of ge...
(Date:11/24/2009)...ts that keep weakened and flabby arteries from col...months, those stents are no longer needed -- once ...sary. Previously, doctors had no choice but to lea...l Aviv University,s Department of Biomedical Engin...atform that carries drugs where they,re needed, th...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3A coating for life 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 1MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 2MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 3MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 4MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 5MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 6MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results 53457 7Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 1Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 1Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 2Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 3Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program 4811 4
...tists replaced a single atom from the molecular st...biotic that attacks the bacteria by inhibiting cel...g,s spectrum of activity. In recent years, a numbe...ecome resistant to vancomycin and use of the antib... effort could help make the drug more effective in...
...hnology for implants that may improve construction...s been developed by researchers from the American ...nal Institute of Standards and Technology (NIST). ...es,* the new technology provides a method for maki...ed with a patient,s own cells and is formed with a...
... in the March 17 issue of Science, their lizard st...-called third, or parietal, eye, distinguishes two...l the time of day. Specialized nerve cells in that... forehead, use two types of molecular signals to s...ike scallops, and those found only in more complex...
Other Biology News:Scientists re-engineer a well-known antibiotic to counter drug resistance 2Bioactive cement scaffold may improve bone grafts 2Lizard 'third eye' sheds light on evolution of color vision 2
Tramadol ELISA Kit, Single from Bio-Quant Inc.
...h Registered OLAW Assured AAALAC Accredited All Pr...ed Technicians Documentation GLP Process for All... CRP is your one stop shopping point for all your ...oject consultation, free peptide sequence recommen...
Dengue Virus IgM ELISA Kit, Single from Bio-Quant Inc.
THC ELISA Kit, Single from Bio-Quant Inc.
Biology Products: